Filters
reset allResults: 1 to 17 of 17
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
PreventionGenetics United States | 285 | 137 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States | 345 | 159 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Invitae Skeletal Disorders Panel Invitae United States | 624 | 349 |
|
Desbuquois dysplasia and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 11 |
|
Desbuquois dysplasia core Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 4 |
|
Desbuquois dysplasia core Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 4 |
|
Desbuquois dysplasia and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 11 |
|
Spondylo-Epi-Metaphyseal dysplasias Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 79 | 54 |
|
Spondylo-Epi-Metaphyseal dysplasias Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 79 | 54 |
|
Desbuquois dysplasia core Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 4 |
|
Desbuquois dysplasia core Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 2 | 4 |
|
Desbuquois dysplasia and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 11 |
|
Desbuquois dysplasia and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 3 | 11 |
|
Invitae Congenital Disorders of Glycosylation Panel Invitae United States | 203 | 152 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Results: 1 to 17 of 17
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.